quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 13, 2026

Should You Buy, Sell or Hold NEM Stock After a 36% Rally in 6 Months?

View original at finance.yahoo.com
“At the end of the first quarter of 2026, Newmont had robust liquidity of roughly $12.8 billion, including cash and cash equivalents of around $8.8 billion.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • NEM stock has outperformed the Zacks Mining – Gold industry's 22.4% gain and the S&P 500's increase of 11.8%, while gold mining peers Barrick, Agnico Eagle, and Kinross gained 23.8%, 17.2%, and 24.7% respectively

    60% confidence
  • Newmont's dividend yield of 0.9% and payout ratio of 12% indicate the dividend is safe and reliable, backed by strong cash flows

    60% confidence
  • Newmont generated $3.6 billion from portfolio optimization actions in 2025 to support capital allocation strategy focused on balance sheet reinforcement and shareholder returns

    60% confidence
  • Newmont reduced debt by roughly $3.4 billion in 2025 and by an additional $42 million in Q1 2026, resulting in a net cash position of $3.2 billion

    60% confidence
  • The NEM stock has been trading above its 200-day SMA since April 9, 2025, and broke above its 50-day SMA on May 6, 2026, with a golden crossover on April 16, 2025, indicating a bullish trend

    60% confidence
  • Ahafo North is expected to produce between 275,000 and 325,000 ounces of gold annually over an estimated mine life of 13 years, with output of 315,000 ounces expected in 2026

    60% confidence
  • At end of Q1 2026, Newmont had liquidity of roughly $12.8 billion including cash and cash equivalents of around $8.8 billion

    60% confidence
  • NEM has distributed $3.4 billion to shareholders through dividends and share repurchases in 2025, and returned $2.7 billion since February 19, 2026

    60% confidence
  • Newmont executed $6 billion in repurchases under prior share purchase programs including $2.4 billion since the Q4 2025 earnings call; board has approved an additional $6 billion repurchase program

    60% confidence
  • Free cash flow surged 161% year over year to a record $3.1 billion in Q1 2026, with net cash from operating activities of $3.8 billion versus $2 billion in the year-ago quarter

    60% confidence
  • Newmont shares have climbed 36.3% in the past six months, fueled by an upswing in gold prices amid economic and geopolitical uncertainties and its forecast-topping earnings performance

    60% confidence

Data points we hold from this source

Newmont Corporation · margin12 percent
Newmont Corporation · market share0.9 percent
Newmont Corporation · debt-42 USD
Newmont Corporation · net income3.1 USD
Newmont Corporation · cash8.8 USD
Newmont Corporation · debt-3.4 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Should You Buy, Sell or Hold NEM Stock After a 36% Rally in 6 Months? — Source | Via News | pt.VIA.NEWS